EP 0783568 A1 19970716 - FIBROBLASTS FOR THE TREATMENT OF MUSCULAR DISORDERS
Title (en)
FIBROBLASTS FOR THE TREATMENT OF MUSCULAR DISORDERS
Title (de)
FIBROBLASTEN ZUR BEHANDLUNG DER MUSKELKRANKHEITEN
Title (fr)
FIBROBLASTES DESTINES AU TRAITEMENT D'AFFECTIONS MUSCULAIRES
Publication
Application
Priority
- GB 9502187 W 19950915
- GB 9419048 A 19940920
Abstract (en)
[origin: GB2293604A] Dermal fibroblast cells comprise a muscle-specific DNA, preferably the dystrophin gene. Dermal fibroblast cells, optionally comprising the above DNA, are used in the preparation of a cell formulation for administration to a patient such that the said cells are converted to myogenic cells able to produce products expressed by muscle-specific genes. The formulations are of use for the treatment of injury resulting in muscular degeneration, or muscular dystrophy, especially Duchenne's.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 35/36 (2015.01); A61P 43/00 (2006.01); C12N 5/077 (2010.01); C12N 5/10 (2006.01); A61K 35/12 (2015.01); A61K 48/00 (2006.01)
CPC (source: EP)
A61K 35/36 (2013.01); A61P 43/00 (2017.12); C12N 5/0656 (2013.01); A61K 35/12 (2013.01); A61K 48/00 (2013.01)
Citation (search report)
See references of WO 9609373A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
GB 2293604 A 19960403; GB 2293604 B 19960911; GB 9518887 D0 19951115; AU 3481695 A 19960409; AU 694957 B2 19980806; CA 2198379 A1 19960328; EP 0783568 A1 19970716; GB 9419048 D0 19941109; JP H10505756 A 19980609; WO 9609373 A1 19960328
DOCDB simple family (application)
GB 9518887 A 19950915; AU 3481695 A 19950915; CA 2198379 A 19950915; EP 95931336 A 19950915; GB 9419048 A 19940920; GB 9502187 W 19950915; JP 51066895 A 19950915